PlaMavax
- Generic Name
- PlaMavax
Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults
Phase 1
Not yet recruiting
- Conditions
- Malaria
- Interventions
- First Posted Date
- 2022-07-01
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 30
- Registration Number
- NCT05441410
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath